文献速递临床试验与 GCP流行病学与生物统计

支持中小企业雇主帮助长期病假员工复工的中小企业工具:随机对照试验及过程评价的研究方案

The SME tool supporting employers of small- and medium-sized enterprises during the return to work of employees on long-term sick leave: study protocol for a randomized controlled trial and for a process evaluation.
PubMed 文献 · Trials · 2024-08-16

本研究为一项平行分组随机对照试验的研究方案,计划招募中小企业(员工数≤250人)中病假≤8周且有长期病假风险的员工及其雇主,以1:1随机分配至干预组(无限制使用基于自我决定理论开发的中小企业工具)或对照组(常规照护),随访6个月。主要结局为员工对雇主提供的复工支持满意度,次要结局包括员工层面的社会支持、工作绩效、工作生活质量及雇主层面的提供复工支持自我效能。同时进行过程评价,包括半结构化访谈,以探索结果解读及全国实施策略。

要点

  • 中小企业工具基于自我决定理论开发,旨在提升雇主支持病假员工复工的意愿和能力。
  • 研究采用随机对照试验设计,员工与雇主作为二元组按1:1随机分配,随访6个月。
  • 主要结局为员工对雇主复工支持的满意度,在基线及1、3、6个月时通过问卷评估。

核心结论

  • 研究假设中小企业工具在常规照护基础上,可通过改善雇主的意愿和能力,有效帮助雇主支持长期病假员工复工。

研究设计与样本

  • 随机对照试验,平行分组设计,两组分别为干预组和对照组,随访6个月。

主要发现

  • 原文为研究方案,未报告研究结果。

关键数值与推荐

  • 纳入对象为中小企业(员工数≤250人)中病假≤8周且有长期病假风险的员工及其雇主。
  • 员工与雇主作为二元组按1:1随机分配。
  • 干预组雇主获得中小企业工具的无限制使用权限,对照组雇主接受常规照护。
  • 主要结局为员工对雇主提供的复工支持满意度。
  • 次要结局包括员工层面的社会支持、工作绩效、工作生活质量,以及雇主层面的提供复工支持自我效能。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Returning to work after long-term sick leave can be challenging, particularly in small- and medium-sized enterprises (SMEs) where support may be limited. Recognizing the responsibilities and challenges of SME employers, a web-based intervention (hereafter the SME tool) has been developed. The SME tool aims to enhance the employer's intention and ability to support the sick-listed employee. Based on the Self-Determination Theory, it is hypothesized that this intention is enhanced by intervening in the employer's autonomy, competences, and relatedness targeted at, e.g., communication with sick-listed employee, involvement of other stakeholders, and practical support. This is achieved by means of providing templates, communication videos, and information on legislation. This article describes the design of an effect and process evaluation of the SME tool. METHODS: A randomized controlled trial (RCT) with a 6-month follow-up will be conducted with a parallel-group design with two arms: an intervention group and a control group. Sick-listed employees (≤ 8 weeks) of SMEs (≤ 250 employees) at risk of long-term sick leave and their employers will be recruited and randomly allocated as a dyad (1:1). Employers randomized to the intervention group receive unlimited access to the SME tool, while those in the control group will receive care as usual. The primary outcome is the satisfaction of the employee with the return to work (RTW) support provided by their employer. Secondary outcomes include social support, work performance, and quality of work life at the employee level and self-efficacy in providing RTW support at the employer level. Outcomes will be assessed using questionnaires at baseline and 1, 3, and 6 months of follow-up. Process evaluation measures include, e.g., recruitment and use of and perceived usefulness of the SME tool. Additionally, semi-structured interviews with employers, employees, and occupational physicians will explore the interpretation of the RCT results and strategies for the national implementation of the SME tool. DISCUSSION: The SME tool is hypothesized to be valuable in addition to usual care helping employers to effectively support the RTW of their long-term sick-listed employees, by improving the employers' intention and ability to support. TRIAL REGISTRATION: ClinicalTrials.gov, NCT06330415. Registered on February 14, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Beerda DCE, Greidanus MA, de Rijk AE, et al. The SME tool supporting employers of small- and medium-sized enterprises during the return to work of employees on long-term sick leave: study protocol for a randomized controlled trial and for a process evaluation. Trials. 2024. PMID: 39152487. doi:10.1186/s13063-024-08383-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。